Brief: Odonate Therapeutics Qtrly Loss Per Share $0.79
30/07/2018 21:27
July 30 (Reuters) - Odonate Therapeutics Inc ODT.O :
* ODONATE THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE
THREE
AND SIX MONTHS ENDED JUNE 30, 2018
* ODONATE THERAPEUTICS INC - AS OF JUNE 30, 2018, ODONATE
HAD
$177.4 MILLION IN CASH
* ODONATE THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.79
Source text for Eikon: ID:nBw7HJ2gta
Further company coverage: ODT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Odonate
See all newsBrief: Odonate Announces Expected Delisting Of Its Stock
Brief: Odonate Therapeutics Announces Planned Return Of Capital To Stockholders Through Share Repurchase Plan
Brief: Odonate Therapeutics Announces Quarterly Loss Per Share Of $0.58
Odonate Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Odonate Therapeutics Inc expected to post a loss of 33 cents a share - Earnings Preview